Recent Posts About Firm News

  • Walk to End Alzheimer's

    We were honored to sponsor the 2015 Walk to End Alzheimer's at Montrose Harbor. Thank you to the volunteers, donors, staff and participants who came out to support this important cause. Together, we raised more than $900,000 toward advancing Alzheimer's care and research. For more information on the Walk and our elder care law practice, follow the links here and here .
    Continue Reading
  • Attorney Bill Pintas Gets a Taste of the Las Vegas "Death Ray"

    Our very own Chicago personal injury attorney, Bill Pintas, experienced the hotter side of Las Vegas (quite literally) while staying at the Vdara Hotel in Las Vegas. Attorney Pintas was actually looking to cool down at the hotel pool when he experienced this heated phenomenon. As he laid back in a chair he was suddenly confronted with uncomfortable temperatures that singed his hair and melted the ...
    Continue Reading
  • Pintas & Mullins Law Firm Prevails Over a Vegas Hotel for $950,000

    Thousands of people vacation in Las Vegas every weekend. It’s not uncommon for many to go home feeling sick over gambling losses. For one of our clients though the illness did not subside when he got home. Mr. Richardson* and his wife stayed at the Polo Tower in Las Vegas for one week celebrating their wedding anniversary and came home with a lifelong illness. He arrived home from Las Vegas ...
    Continue Reading
  • Pintas & Mullins Law Firm wins record $2.7 million nursing home case

    The decision to place a family member in a nursing home is difficult and often heart wrenching. Once this decision is made, trust is placed in the nursing home to administer the best care. One of our clients trusted a nursing home to attend and monitor her mother, Veronica,* but discovered neglect instead. Veronica was admitted to the nursing home for extended rehabilitation following a surgical ...
    Continue Reading
  • Record win of $1.25 Million Settlement in Broken Femur Case

    As citizens, we trust that our public transportation system will provide us with dependable and competent drivers. This trust was broken for one of our clients, who, because of the negligent action of a bus driver, unfortunately will never be able to fully use his right leg again. On the day of the accident our client, a teenage boy, stepped in front of a stopped CTA bus. The bus driver mistakenly ...
    Continue Reading
  • Celebrex Receives Black Box Warning

    Blackbox Warnings Added to Celebrex Label On April 7, 2005, the FDA forced Pfizer to add its sternest warning for a medication. The "black box" warnings alert consumers of the serious cardiovascular risks such as heart attacks and strokes. Studies as far back as 1999 and as recent as December of 2004 link Celebrex with an increased risk of cardiovascular events. The FDA considered the findings of ...
    Continue Reading
  • Cox-2 Inhibitors Linked to Cardiovascular Issues

    You have probably seen or read about Cox inhibitors in the news recently. All Cox inhibitors are part of a class of drugs called non-steroidal anti-inflammatory drugs (NSAID). While successful for millions of Americans in reducing pain, certain NSAIDs have long been associated with serious cardiovascular problems. NSAIDs work by inhibiting proteins called cyclo-oxygenase 1 and 2 (Cox 1 & Cox 2). ...
    Continue Reading
  • FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex

    FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex FOR IMMEDIATE RELEASE: Statement - Dec. 17, 2004 The FDA today released the following statement on the halting of a clinical trial of the Cox-2 inhibitor Celebrex (celecoxib): The Food and Drug Administration (FDA) learned last night from the National Cancer Institute (NCI) and Pfizer, Inc., that NCI has stopped drug ...
    Continue Reading
  • Vioxx Recalled for Suspected Link to Heart Conditions

    On September 30, 2004, Merck Pharmaceuticals voluntarily withdrew the drug Vioxx from the market. The withdrawal came after the conclusion of a long clinical study to test the effectiveness of the drug on the reduction of colon polyps. During that study, it became clear that people on the drug for more than eighteen months were at twice the risk for heart attacks, strokes, and other serious ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.